Activity Provided By:

Relias LLC

Networks in Neurology: Insights From a Collaborative CME Experience With Practicing Clinicians Regarding New Agents and Strategies for Multiple Sclerosis

Overview / Abstract:	Upon completion of this activity, participants should be better able to: Review the limitations associated with the use of historical S1P receptor modulators and fumarates and how novel formulations address these challenges to determine the appropriate role and patient selection for these agents in clinical practice. Discuss the rationale for, experience with, and unique features of agents with novel mechanisms of action and alternative anti-CD20 formulations to help guide their optimal utilization across patients with varied presentations of MS. Evaluate published research with and ongoing Phase 3 evaluation of rising BTK inhibitors to discern the potential future role of these agents in the long-term care of patients with MS.
Expiration	Nov 30, 2022
Format	Webinar / Webcast / Video
Credits / Hours	0.75
Accreditation	ACCME, ANCC
Presenters / Authors / Faculty	Robert Naismith, MD (Chair) Professor, Neurology Clinic Director, John L. Trotter Multiple Sclerosis Center Director, Multiple Sclerosis Clinical Trials Program Washington University School of Medicine St. Louis, Missouri Erin Longbrake, MD, PhD (Panelist) Assistant Professor of Neurology Program Director, Neuroimmunology Fellowship Director, Clinical Research in Neuroimmunology Yale University New Haven, Connecticut Darin Okuda, MD (Surveyed Expert) Professor of Neurology Director, Neuroinnovation Program Director, Multiple Sclerosis & Neuroimmunology Imaging Program UT Southwestern Medical Center Dallas, Texas Carrie Hersh, DO, MSc, FAAN (Surveyed Expert) Assistant Professor of Neurology Director \| Multiple Sclerosis Health and Wellness Program Cleveland Clinic Mellen Program for Multiple Sclerosis Lou Ruvo Center for Brain Health Las Vegas, Nevada Riley Bove, MD (Surveyed Expert) Assistant Professor of Neurology Director of Digital Innovation, UCSF MS and Neuroinflammation Center UCSF Weill Institute for Neurosciences San Francisco, California Eric Klawiter, MD, MSc (Group Leader) Associate Neurologist Associate Professor of Neurology Massachusetts General Hospital/Harvard Medical School Boston, MA
Sponsors / Supporters / Grant Providers	Postgraduate Institute for Medicine (PIM); Efficient LLC.; Biogen, Bristol-Myers Squibb; EMD Serono; Sanofi.
Keywords / Search Terms	Relias LLC Multiple Sclerosis, Neurology Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map